george fisher, MD PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    astra zeneca
    Topic:
    data safety monitoring board
    Date added:
    09/22/2023
    Date updated:
    09/22/2023
    Relationship end date:
    09/01/2024
  • Attribution:
    Spouse or Partner
    Type of financial relationship:
    Stock
    Ineligible company:
    seattle genetics
    Topic:
    wife owns stock
    Date added:
    09/22/2023
    Date updated:
    09/22/2023
    Relationship end date:
    09/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    hutchison pharma
    Topic:
    data safety monitoring board
    Date added:
    09/22/2023
    Date updated:
    09/22/2023
    Relationship end date:
    03/01/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    genentech/roche
    Topic:
    advisory board
    Date added:
    09/22/2023
    Date updated:
    09/22/2023
    Relationship end date:
    09/02/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    merck
    Topic:
    advisory board
    Date added:
    09/22/2023
    Date updated:
    09/22/2023
Return to 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes